Catalyst Said to Take Therapure Public, Weighs Casino IPOBy and
Private equity firm to raise more than $75 million in IPO
Mississauga-based Therapure focuses on biopharmaceuticals
Catalyst Capital Group Inc., a Canadian private equity firm, is seeking to raise at least C$100 million ($75 million) in an initial public offering of Therapure Biopharma Inc., according to people familiar with the sale.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.